SUMMER BLAIR: Open Payments
NPI 1245683697 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87 in 5 payments from 4 companies in 2025. Trend: 2023 $342 · 2024 $284 · 2025 $87
Food & beverage: $87
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $17 |
| Boston Scientific Corporation | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: FANAPT, VRAYLAR, WaveWriter Alpha Prime 16, Veozah.
Industry payments across KY — which companies pay providers there.
